(Halifax, NS) Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of the virus quickly and before it can spread. Building on the recent results of a pilot study, the research team has begun to collect… Read More
News & Awards
LuminUltra and BuiltSpace partner with UBC scientists to test cleaning protocols, reducing the risk of COVID-19 spread in indoor educational spaces
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia (UBC) to test the effectiveness of disinfection efforts in educational settings for early detection of SARS-CoV-2, the virus that causes COVID-19. “The battle against COVID-19 requires… Read More
Made-in-Canada COVID Testing Now Available: LuminUltra Receives Health Canada Authorization for Rapid, Portable COVID-19 qPCR Testing Solutions
LuminUltra’s point-of-need and high-volume testing solutions capable of serving a range of COVID testing needs in under two hours FREDERICTON, NB, December 3, 2020 – Biotechnology front-runner LuminUltra is pleased to announce that it has received Health Canada authorization to sell and distribute its GeneCount® COVID-19 RT-qPCR Assay Kit. This authorization allows LuminUltra, the Canadian… Read More
LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of uses cases…. Read More
LuminUltra partners with The Infection Prevention Strategy to educate on proper COVID-19 disinfection protocol
Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management CANADA – Nov. 18, 2020 – Biotechnology leader LuminUltra has partnered with The Infection Prevention Strategy (TIPS) in the fight against COVID-19 to provide global education on the importance of verifying proper disinfection protocols with science-based methodology. As a global leader in molecular diagnostic testing, LuminUltra has developed portable qPCR technology that can test for the presence of SARS-CoV-2 –… Read More
A Research Collaboration Between LuminUltra, Dalhousie University and Halifax Water Demonstrates Wastewater Data Is a Powerful Tool in Early Detection and Tracking COVID-19 Prevalence within Communities FREDERICTON, NB, October 21, 2020 – LuminUltra, a Canada-based biotechnology leader and portfolio company of XPV Water Partners, recently filed a patent for the first complete, rapid, and on-site… Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.
Atlantic Business Magazine has named LuminUltra Technologies Ltd.’s Chairman & CEO, Pat Whalen, to their 2020 Top 50 CEO list. Read the full story here.
NGen has announced $3.5 million in project funding in support of Canada’s COVID-19 response, which includes support for LuminUltra’s scale-up.
Until a COVID-19 Vaccine is Available, Widespread Environmental Testing for SARS-CoV-2, Coupled with Effective Disinfection Regimen, Shortens Path to Preserving Public Confidence and Enabling Facilities to Remain Open Amidst Periodic Flare-Ups New Brunswick, Canada – LuminUltra, the Canadian biotechnology leader and developer of the GeneCount® qPCR system, and Florida-based Source Molecular, a leader in pathogen… Read More